Lisocabtagene Maraleucel (Liso-cel) in Patients with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) Treated As Outpatients or Inpatients in the Community/Nonuniversity Setting: Patient-Reported Outcomes/Health-Related Quality of Life from the Outreach Study

Authors :: Yuliya Linhares
Fei Fei Liu
Cesar Freytes
Mohamad Cherry
Ling Shi
Weiqin Liao
Julia Braverman
Ricardo Espinola
Min Vedal
Bassam Mattar
Source :: Blood. 140:10930-10931
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools